Current Liabilities $17.08M as at 31 Dec 2019
Current Liabilities $9.61M as at 30 June 2020
Significant reduction of $7.47M
- Forums
- ASX - By Stock
- GMV
- Ann: Half Year Accounts
Ann: Half Year Accounts, page-51
-
-
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online